Citizens Maintains Market Outperform on Exelixis, Raises Price Target to $55
Benzinga Newsdesk 4 months ago
Analyst RatingsNewsPrice Target
Citizens analyst Silvan Turkcan maintains Exelixis (NASDAQ:EXEL) with a Market Outperform and raises the price target from $50 to $55.
Citizens analyst Silvan Turkcan maintains Exelixis (NASDAQ:EXEL) with a Market Outperform and raises the price target from $50 to $55.